Research Triangle Park, N.C. — Despite problems in Europe, GSK's Andrew Witty remains optimistic about the company's future. "[W]e really feel like the strategic anchors of the company are starting to look very, very promising. And that's why we remain committed to the view that we can get pretty quickly back to sustainable sales growth."...